Pulmonology/Critical Care Flashcards
 Management for pulmonary nodule that is smaller than 6 mm in size in patients who have low risk for malignancy
No further follow up
Clinical presentation of sarcoidosis that do not require biopsy
1) asymptomatic stage one pulmonary sarcoidosis
2) Lofgren syndrome
3) Heerfordt syndrome
Appropriate evaluation for patients with asthma symptoms and normal spirometry
Methacholine challenge test
Preferred treatment for VTE disease in pregnant patients
LMWH
Bulky symptomatic mass with mediastinal involvement and is associated with paraneoplastic syndromes, most frequently SIADH
Small cell lung cancer
Diagnostic triglyceride level for chylothorax
Greater 110 mg/dL
Management for incidental groundglass (subsolid) pulmonary nodule >6 mm that has been stable at 6 to 12 month follow-up CT chest
Repeat CT at 2 year Intervals for 5 years
Fever, bilateral hilar LAD, EN, ankle arthritis
Lofgren syndrome
Anterior uveitis, parotid gland enlargement, facial palsy, fever
Heerfordt syndrome
Pleural plaques, diffuse pleural thickening, rounded atelectasis
Asbestos-related lung syndromes
Fleishner recommendation for follow-up of single pulmonary nodule < 6mm in low risk patient.
No follow up
Fleishner recommendation for follow-up of solitary subsolid/pure ground glass lung nodule > 6mm
CT at 6-12 mo to confirm persistence, then CT every 2 years until 5 years
Fleishner recommendation for follow-up of solitary subsolid/part solid lung nodule > 6mm
CT at 3-6 mo to confirm persistence. If unchanged and solid component remains < 6mm, annual CT should be performed every 5 years
Fractional exhaled nitric oxide levels which correlate with eosinophilic airway inflammation and predict response to inhaled glucocorticoid
> 50 ppb
Respiratory insufficiency, Neurologic dysfunction, petechial rash
Fat embolism syndrome
